Non-Hodgkin's Lymphoma News
-
Blood Test May Predict Lymphoma Response
A blood test that checks the level of tumor cells before and after cancer treatment could tell doctors within days or weeks, rather than months, whether the treatment has been effective, researchers report.
-
FDA Approves First-of-Its-Kind Cancer Treatment
The FDA has approved a first-of-its-kind treatment, called CAR T-cell therapy, to treat a type of leukemia in children and young adults.
-
Drug Helps Some Kids With Rare Type of Leukemia
Dasatinib prolonged survival in chronic myeloid leukemia patients, study says
-
Gleevec Keeps a Leukemia in Check for Decade Plus
Plus, there's no evidence of safety concerns linked to long-term use of the drug, researchers say
-
Gene Therapy Shows Promise for Aggressive Lymphoma
Over one-third of patients appeared disease-free 6 months after single treatment, report says
-
Gene Therapy Helps 2 Babies Fight Type of Leukemia
Tweaking T-cells from healthy donor allowed infants to reach remission, researchers report
-
Therapeutic Vaccine Promising Against a Leukemia
Made by combining immune cells, cancer cells, it's kept some study patients in remission for nearly 5 years
-
Therapy 'Step Forward' for Non-Hodgkin Lymphoma
Early trial results termed 'fantastic step forward' in fight against non-Hodgkin lymphoma
-
Cord-Blood Transplants Show Promise for Leukemia
Donors and recipients don't need to be a perfect match, researcher says
-
New Drug Shows Promise for Rare Blood Cancers
Organ damage improved in 60 percent of patients with advanced systemic mastocytosis
-
Scans May Spare These Patients From Chemo
Test finds those who might respond well, may spare others treatment side effects
-
This Can Help HIV Patients Battling Lymphoma
Outcomes after the therapy similar to those for patients who don't carry the virus
-
Generic Gleevec Will Likely Save Millions in Costs
Over 5 years, researchers estimate more than $9 million in insurance savings
-
This May Boost Leukemia Stem Cell Transplant
Study showed many were able to avoid graft-versus-host disease
-
First Generic Version of Gleevec Approved by FDA
First Generic Version of Gleevec Approved by FDA
-
Gene Editing Reverses Baby's Leukemia
Doctors in the United Kingdom have successfully treated a baby girl with incurable leukemia by using a gene-editing technique that had been tested only in the laboratory. WebMD shares the details.
-
Could Common Diabetes Drugs Help Fight Leukemia?
Combining glitazones with standard treatment improved survival in small study
-
Another Genetic Error Linked to Childhood Leukemia
Researchers find gene variant associated with acute lymphoblastic leukemia
-
Hodgkin's Lymphoma Survivors Face Higher Long-Term Heart Risks
Study suggests chemotherapy, radiation can damage the heart for decades to come
-
New Drug May Help Keep Hodgkin Lymphoma at Bay
In study, brentuximab extended time patients survived without further progression of the blood cancer
-
Hodgkin Lymphoma Treatment Shows Promise in Small Trial
Nivolumab harnesses power of immune system to attack cancer in patients who've failed other therapy
-
Immunotherapy Brings New Hope to Cancer Fight
Cancer patients are finding new hope -- and even remission -- in an experimental treatment called immunotherapy.
-
Immune Therapy Induces Remission for Many With a Tough-to-Treat Blood Cancer
But, some advanced acute lymphoblastic leukemia patients relapsed, study finds
-
FDA Approves Imbruvica for Chronic Leukemia
Drug inhibits enzyme that spurs cancer growth
-
Gene Therapy Shows Promise Against Leukemia, Other Blood Cancers
In many patients in early trials, turning T-cells into cancer fighters sent disease into remission
Pagination